TEVA
Teva Pharmaceutical Industries Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$38.98
−0.54%Forward multiples
Based on analyst estimates
- P/E forward
- 13.93x
- P/E 2026E
- 19.70x
- P/E 2027E
- 12.75x
- P/E 2028E
- 11.39x
- P/S forward
- 2.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- 61.87x
- PEG TTM
- 0.18x
- Price / book
- 5.86x
- Price / sales
- 2.63x
- Price / cash flow
- 23.95x
Enterprise value
- Enterprise value
- $58.7B
- EV / sales
- 3.39x
- EV / EBITDA
- 22.62x
- EV / EBIT
- 29.59x
- Market cap
- $45.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026